Bottom line
PRHSX vs BHCHX: the short answer
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and BHCHX (Baron Health Care Fund) share a meaningful slice of their top holdings — about 50% by weight.
But PRHSX is far broader, holding 279 positions to 43 for BHCHX, so beyond the top names it adds exposure BHCHX doesn't have.
PRHSX is cheaper at 0.83% vs 0.85% — a difference of $2.00 a year per $10,000 invested.
Over five years, PRHSX returned +4.2% a year vs +2.8% for BHCHX.
Updated Nov 19, 2026
PRHSX vs BHCHX side by side
| PRHSX | BHCHX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | T. Rowe Price | Baron Select |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.83% | 0.85% |
| Annual cost per $10k | $83 | $85 |
| 10-yr cost on $10k (prospectus) | $1,025 | $1,049 |
| Max front load | — | — |
| 12b-1 fee | — | 0% |
| 1-yr return | +17.7% | +10.3% |
| 5-yr return (annualized) | +4.2% | +2.8% |
| 10-yr return (annualized) | +9.1% | — |
| Best quarter | +23.5% | — |
| Worst quarter | −15.8% | — |
| Net assets (fund) | $11.9B | $114.1M |
| Number of holdings | 279 | 43 |
| Portfolio turnover | 62% | 74% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
13 of PRHSX's top 25 holdings also appear in BHCHX's top 25.
| Holding | PRHSX | BHCHX |
|---|---|---|
| Eli Lilly & Co | 14.28% | 13.66% |
| Johnson & Johnson | 6.63% | 5.56% |
| Unitedhealth Group Inc | 5.99% | 3.28% |
| Merck & Co. Inc. | 4.01% | 2.48% |
| Gilead Sciences Inc | 2.82% | 1.99% |
| Thermo Fisher Scientific Inc | 2.52% | 3.91% |
| Vertex Pharmaceuticals Inc | 2.28% | 2.61% |
| Intuitive Surgical Inc | 1.87% | 1.74% |
| Elevance Health Inc | 1.53% | 1.69% |
| Natera Inc | 1.44% | 1.93% |
| Guardant Health Inc | 1.23% | 2.17% |
| Kymera Therapeutics Inc | 0.89% | 2.01% |
| Protagonist Therapeutics Inc | 0.85% | 1.72% |
Source: SEC Form N-PORT
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
BHCHX top 10
- Eli Lilly & Co — 13.66%
- Mettler-Toledo International Inc — 5.60%
- Johnson & Johnson — 5.56%
- Argenx SE — 4.23%
- Thermo Fisher Scientific Inc — 3.91%
- Roivant Sciences Ltd — 3.88%
- Teva Pharmaceutical Industries Ltd — 3.86%
- Welltower Inc — 3.38%
- UnitedHealth Group Inc — 3.28%
- RadNet Inc — 3.24%
FAQ
What is the difference between PRHSX and BHCHX?
Which is cheaper, PRHSX or BHCHX?
Should I own both PRHSX and BHCHX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.